SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-20-000074
Filing Date
2020-09-02
Accepted
2020-09-02 09:00:57
Documents
18
Period of Report
2020-08-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rare-20200828.htm   iXBRL 8-K 76037
2 EX-10.1 rare-20200828-ex10_1.htm EX-10.1 69694
3 EX-10.2 rare-20200828-ex10_2.htm EX-10.2 112696
4 EX-99.1 rare-20200828-ex99_1.htm EX-99.1 13584
5 GRAPHIC img_0.jpg GRAPHIC 375412
6 GRAPHIC img_1.jpg GRAPHIC 375412
7 GRAPHIC img_2.jpg GRAPHIC 375412
  Complete submission text file 0000950170-20-000074.txt   1978572

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rare-20200828.xsd EX-101.SCH 2249
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rare-20200828_lab.xml EX-101.LAB 13605
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rare-20200828_pre.xml EX-101.PRE 10043
11 EXTRACTED XBRL INSTANCE DOCUMENT rare-20200828_htm.xml XML 4750
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 201155795
SIC: 2834 Pharmaceutical Preparations